[go: up one dir, main page]

MX2017009419A - Uso de enzimas con una amplia gama de actividades como medicamentos para favorecer la digestion. - Google Patents

Uso de enzimas con una amplia gama de actividades como medicamentos para favorecer la digestion.

Info

Publication number
MX2017009419A
MX2017009419A MX2017009419A MX2017009419A MX2017009419A MX 2017009419 A MX2017009419 A MX 2017009419A MX 2017009419 A MX2017009419 A MX 2017009419A MX 2017009419 A MX2017009419 A MX 2017009419A MX 2017009419 A MX2017009419 A MX 2017009419A
Authority
MX
Mexico
Prior art keywords
enzymes
medicaments
wide
promoting digestion
activity range
Prior art date
Application number
MX2017009419A
Other languages
English (en)
Other versions
MX395382B (es
Inventor
Wolf William HARTMANN Marcus
ALDAG Ingo
Original Assignee
Cilian Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cilian Ag filed Critical Cilian Ag
Publication of MX2017009419A publication Critical patent/MX2017009419A/es
Publication of MX395382B publication Critical patent/MX395382B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se da a conocer una combinación de dos o más enzimas lipasa, y su uso para tratar deficiencia en la digestión de lípidos y / o trastorno digestivo. Al menos una enzima lipasa tiene un pH óptimo a un valor de pH ácido, mientras que al menos otra enzima lipasa tiene un pH óptimo a un valor de pH alcalino.
MX2017009419A 2015-01-22 2016-01-22 Uso de enzimas con una amplia gama de actividades como medicamentos para favorecer la digestion. MX395382B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1501081.2A GB201501081D0 (en) 2015-01-22 2015-01-22 Use of enzymes with a wide pH activity range as medicaments for promoting digestion
PCT/EP2016/051341 WO2016116600A1 (en) 2015-01-22 2016-01-22 Use of enzymes with a wide ph activity range as medicaments for promoting digestion

Publications (2)

Publication Number Publication Date
MX2017009419A true MX2017009419A (es) 2018-01-18
MX395382B MX395382B (es) 2025-03-25

Family

ID=52673797

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017009419A MX395382B (es) 2015-01-22 2016-01-22 Uso de enzimas con una amplia gama de actividades como medicamentos para favorecer la digestion.

Country Status (12)

Country Link
US (2) US10590402B2 (es)
EP (1) EP3247385A1 (es)
JP (1) JP7075758B2 (es)
KR (1) KR102601352B1 (es)
CN (1) CN107872978B (es)
AU (1) AU2016208474B9 (es)
CA (1) CA2992918A1 (es)
GB (1) GB201501081D0 (es)
IL (1) IL253618B (es)
MX (1) MX395382B (es)
RU (1) RU2721708C2 (es)
WO (1) WO2016116600A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201501081D0 (en) 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion
EP4172325A1 (en) 2020-06-24 2023-05-03 Cilian AG New lipase enzyme
CA3212187A1 (en) 2021-04-09 2022-10-13 Marcus Wolf William HARTMANN Purification of proteins

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991180A (en) * 1972-03-06 1976-11-09 Rohm And Haas Company Stabilization of internally administered pancreatic lipase
SE454566B (sv) 1984-04-24 1988-05-16 Lars G I Hellgren Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus
US4944944A (en) * 1987-11-19 1990-07-31 Oklahoma Medical Research Foundation Dietary compositions and methods using bile salt-activated lipase
DK173590D0 (da) * 1990-06-06 1990-07-19 Novo Nordisk As Rekombinante terapeutiske lipaser
FR2699179B1 (fr) 1992-12-16 1995-01-06 Jouveinal Inst Rech Acides nucléiques codant pour la lipase gastrique de chien et dérivés polypeptidiques, leur utilisation pour la production de ces polypeptides, et compositions pharmaceutiques à base de ces derniers.
EP0828509B1 (en) 1995-05-31 2005-01-26 Medzyme N.V. Composition to improve digestibility and utilisation of nutrients
WO2000046373A1 (en) 1999-02-04 2000-08-10 University Of Georgia Research Foundation, Inc. Diagnostic and protective antigen gene sequences of ichthyophthirius
US7238355B1 (en) * 1999-02-26 2007-07-03 Kirin Beer Kabushiki Kaisha Coated material and process for producing the coated material
US20010010928A1 (en) 1999-03-26 2001-08-02 Stephen M. Beverley Protozoan expression system
US20010046493A1 (en) 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
CA2427537A1 (en) 2000-11-02 2002-05-10 Cilian Ag Use of enzymes obtained from ciliates as medicaments for promoting digestion
AR032392A1 (es) 2001-01-19 2003-11-05 Solvay Pharm Gmbh Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.
DE10106660A1 (de) 2001-02-12 2002-08-29 Celanese Ventures Gmbh Verfahren zur Herstellung von gamma-Linolensäure aus einer Ciliaten-Kultur durch Zusatz geeigneter Vorläufermoleküle zu dem Kulturmedium
US6534303B2 (en) 2001-03-13 2003-03-18 Council Of Scientific & Industrial Research Process for the preparation of acidic lipase
CN100445391C (zh) * 2002-12-02 2008-12-24 巴斯福股份公司 L-鼠李糖-诱导型表达系统
EP1612596A1 (en) 2004-06-29 2006-01-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. High-efficient, tuneable and switchable optical elements based on polymer-liquid crystal composites and films, mixtures and a method for their production
JP4394598B2 (ja) * 2004-08-24 2010-01-06 日清オイリオグループ株式会社 リパーゼ粉末組成物及びそれを用いたエステル化物の製造方法
WO2006044529A1 (en) 2004-10-14 2006-04-27 Altus Pharmaceuticals Inc. Compositions containing lipase; protease and amylase for treating pancreatic insufficiency
DE602006020140D1 (de) 2005-07-13 2011-03-31 Cilian Ag Hitzeinduzierbare tetrahymena-promotoren und deren verwendung
WO2007053619A2 (en) * 2005-11-01 2007-05-10 Bio-Cat, Inc. A composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrous as well as people suffering from pancreatic lipase insufficiency
US8246950B2 (en) 2007-02-20 2012-08-21 Aptalis Pharma Limited Stable digestive enzyme compositions
FR2918846B1 (fr) * 2007-07-20 2013-07-26 Isl Innovation Sante Lipides Composition alimentaire pour ameliorer la digestibilite des lipides alimentaires
US7790429B2 (en) 2007-11-28 2010-09-07 Transbiodiesel Ltd. Robust multi-enzyme preparation for the synthesis of fatty acid alkyl esters
US8268305B1 (en) 2011-09-23 2012-09-18 Bio-Cat, Inc. Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
CN102660528A (zh) * 2012-05-16 2012-09-12 苏州先阔生物科技有限公司 复合碱性脂肪酶组合物、肠溶片及其应用
CN104031899B (zh) 2013-03-05 2016-04-13 中国科学院天津工业生物技术研究所 一种脂肪酶及其应用
CN103266094B (zh) 2013-05-23 2015-02-25 天宁香料（江苏）有限公司 一种复合脂肪酶及其应用
CN105524905A (zh) * 2014-09-29 2016-04-27 湖南新鸿鹰生物工程有限公司 一种含酸性蛋白酶的酱油复合酶及其制备方法
GB201501081D0 (en) 2015-01-22 2015-03-11 Cilian Ag Use of enzymes with a wide pH activity range as medicaments for promoting digestion

Also Published As

Publication number Publication date
CA2992918A1 (en) 2016-07-28
KR20170105104A (ko) 2017-09-18
CN107872978B (zh) 2021-11-26
AU2016208474A1 (en) 2017-09-07
EP3247385A1 (en) 2017-11-29
GB201501081D0 (en) 2015-03-11
IL253618B (en) 2021-10-31
AU2016208474B2 (en) 2021-04-01
RU2017129598A3 (es) 2019-02-21
US10590402B2 (en) 2020-03-17
RU2721708C2 (ru) 2020-05-21
US20180073001A1 (en) 2018-03-15
IL253618A0 (en) 2017-09-28
JP2018504118A (ja) 2018-02-15
US11584920B2 (en) 2023-02-21
WO2016116600A1 (en) 2016-07-28
RU2017129598A (ru) 2019-02-21
MX395382B (es) 2025-03-25
BR112017015782A2 (pt) 2018-03-27
JP7075758B2 (ja) 2022-05-26
AU2016208474B9 (en) 2021-04-22
KR102601352B1 (ko) 2023-11-10
CN107872978A (zh) 2018-04-03
US20200071683A1 (en) 2020-03-05

Similar Documents

Publication Publication Date Title
MX2019007143A (es) Procesamiento de materiales de biomasa.
MX2019003250A (es) Uso de alfa-1,4/1,6-glucosido hidrolasas activas a ph bajo como aditivo alimentario para rumiantes para mejorar la digestion de almidon.
AR087928A1 (es) Aditivo para alimentos que comprende enzimas amidasas
BR112016000954A2 (pt) processo para fracionamento da biomassa lignocelulósica; líquor, polpa ou hidrolisado enzimático de organossolve; e uso de um líquido de tratamento para fracionamento de biomasssa lignocelulósica
MX2016009810A (es) Uso de una composicion enzimatica en la alimentacion para rumiantes.
BR112015028193B8 (pt) Suporte para cicatrização de feridas
AU320783S (en) Oval vial with spline insert
CO6470854A2 (es) Variantes de celulasa con expresión, actividad y/o estabilidad mejoradas, y uso de las mismas
CL2013000123A1 (es) Una interconexion para unir piezas que posee una primera pieza con al menos dos primeras proyecciones incluyendo al menos un primer elemento de interconexion, una segunda pieza con una pluralidad de segundos elementos de interconexion y una pluralidad de segundas proyecciones, donde una de las primeras o segundas piezas es una base y la otra, es una cubierta de un pallet; método para interconectar piezas; y metodo para desensamblar piezas.
CO2022003608A2 (es) Cianopirrolidinas sustituidas con actividad como inhibidores de usp30
CO6280048A1 (es) Artículo absorbente que incluye un núcleo que tiene una pluralidad de primeras regiones y una segunda región alrededor de las primeras regiones.
BR112012013720A2 (pt) uso cosmético de pelo menos um microorganismo probiótico, especialmente do gênero lactobacillus sp.e processo cosmético.
BR112016002498A2 (pt) método para reduzir o teor de ácidos hexenurônicos em uma polpa celulósica química e/ou melhorar o brilho de polpa celulósica química, composição aquosa, e, utilização de uma haloperoxidase
CL2012002902A1 (es) Cepas de bacteriofagos especifica contra bacterias pertenecientes al genero vibrio para la profilaxis y terapia de vibrio anguillarum; y composicion antibacteriana que comprende dicha cepas.
CA142107S (en) Log splitting wedge
CL2014003569A1 (es) Método de producción de iduronato-2-sulfatasa (i2s), que comprende cultivar células de mamíferos que coexpresan i2s recombinante y una enzima generadora formilglicina (fge); preparación de proteína i2s; composición farmacéutica; y uso para tratar síndrome de hunter.
MX2017009419A (es) Uso de enzimas con una amplia gama de actividades como medicamentos para favorecer la digestion.
BR112018000074A2 (pt) micro-organismo para produzir l-lisina e método para produzir l-lisina com o uso do mesmo
UY32896A (es) Composiciones de enzimas pancreáticas y métodos para tratar pancreatitis e insuficiencia pancreática
BR112016006321A2 (pt) enzima engenheirada tendo atividade aceto acetil-coa hidrolase, micro-organismos compreendendo a mesma, e processos de uso da mesma
WO2014136065A8 (en) Production of catalytically active type i sulfatase
BR112013006004A2 (pt) celulose nano-desagregada
WO2011097221A3 (en) Methods of promoting tissue growth and tissue regeneration
BR112013008689A2 (pt) composição de hidrofobina e composição alimentícia
CO2017005383A2 (es) Composiciones inhibidoras